Back to top anchor

Accessing earlier prediabetic treatment in pregnancy

Year:
2021
Duration:
12 months
Approved budget:
$11,317.00
Researchers:
Dr Charlotte Oyston
Proposal type:
Health Delivery Research Activation Grant
Lay summary
Diabetes in pregnancy is associated with worse outcomes for mothers and their babies, identifying and treating diabetes in pregnancy reduces the risks of these complications. To identify mothers with diabetes, pregnant women have an HbA1c blood test as part of their first antenatal screen. National guidelines outline a clear pathway for women who have a normal, or high (diabetic) HbA1c result. The best management for women with an HbA1c result indicating prediabetes (HbA1c higher than normal, but below the threshold for diabetes) is unclear. This has led to regional variation in management of prediabetic pregnant women. A clinical trial is needed to determine if early treatment is beneficial and acceptable. To optimise the design for such a study, we need to engage with those who provide care for women with diabetes in pregnancy in New Zealand to determine current management, and willingness to participate in this research.